SLX (flat): Finished broadly flat despite weakness across uranium names, a relatively encouraging reaction to a result where the headline loss was worse than expected but revenue surprised materially to the upside. For Silex, the P&L remains a secondary consideration at this stage — it all boils down to the commercialisation of its enrichment technologies. With a well-funded balance sheet and tangible progress at the Quantum Silicon facility, there was enough in the update to keep that story moving forward.
Key results:
- Revenue from continuing operations of A$21.6m, up 77% and more than double the A$10m expected, albeit against just two estimates.
- Net loss of A$38.6m, improving from a A$42.6m loss last year but wider than the A$34.9m consensus loss.
- Cash and term deposits of A$180.7m at year-end, with no debt.
The balance sheet is important because SLX remains firmly in investment mode. There is still substantial funding runway, while construction of the first full-scale Quantum Silicon Production Plant in Sydney is now complete. Integration and commissioning are underway, with first samples of enriched silicon-28 — a potential input for next-generation silicon-based quantum computers — is on track for Q1 CY27. That provides another tangible commercialisation milestone alongside the longer-dated uranium enrichment opportunity that continues to underpin much of the valuation.
MM’s view: Judging SLX on whether it beat FY26 earnings consensus misses the forest for the trees. This remains a technology commercialisation story where milestones, funding runway and ultimately proving the economics of its enrichment technology matter far more than today’s revenue or losses. On that score, the update was constructive: revenue surprised positively, cash burn was much better than feared, the balance sheet remains well funded and Quantum Silicon has moved from construction into commissioning. There’s still plenty of execution risk and SLX needs to turn technical progress into commercial outcomes to justify its valuation, but holding flat on a weak day for uranium stocks is just cause to stay patient.
MM remains long and bullish SLX
Add To Hit List
